Multiple Sclerosis Trial, Recruiting (NCT04798651)

Multiple Sclerosis Trial, Recruiting NCT04798651 Sponsor: University Hospital, Bordeaux Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT04798651 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People of any gender aged 18 or older
People who have been diagnosed with multiple sclerosis (MS) according to a specific set of diagnostic guidelines (the 2010 revised McDonald criteria), or who have had a first episode of symptoms that may suggest MS (sometimes called a clinically isolated syndrome)
People who are already scheduled to have a blood draw and/or a spinal fluid sample (lumbar puncture) taken as part of their normal diagnosis or treatment
People who are covered by a health insurance system
People who agree to take part in the study

Who may not be able to join:

Women who are pregnant or breastfeeding
People who are deprived of their liberty by a court or government decision (for example, those who are detained)
People who are minors (under 18 years old)
Adults who are under a legal protection order or who are unable to give their own consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aurélie RUET, Prof, University Hospital, Bordeaux

Phone: 05 56 79 55 21

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04798651

Sponsor: University Hospital, Bordeaux

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 05 56 79 55 21

More information: https://clinicaltrials.gov/study/NCT04798651

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People of any gender aged 18 or older
People who have been diagnosed with multiple sclerosis (MS) according to a specific set of diagnostic guidelines (the 2010 revised McDonald criteria), or who have had a first episode of symptoms that may suggest MS (sometimes called a clinically isolated syndrome)
People who are already scheduled to have a blood draw and/or a spinal fluid sample (lumbar puncture) taken as part of their normal diagnosis or treatment
People who are covered by a health insurance system
People who agree to take part in the study

Who may not be able to join:

Women who are pregnant or breastfeeding
People who are deprived of their liberty by a court or government decision (for example, those who are detained)
People who are minors (under 18 years old)
Adults who are under a legal protection order or who are unable to give their own consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Bordeaux

Registry

ClinicalTrials.gov

Start date

30 September 2021

Est. completion

1 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Functional and phenotypical characterization of the blood and CSF lymphocytes in MS and CIS patients.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov